We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Alphabet (GOOGL) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. The potential of ...

AI is rapidly advancing, with significant strides being made toward achieving more powerful and capable systems. While challenges and limitations have arisen along the way, the field is still ...

Alphabet (GOOGL) missed Wall Street’s expectations for the fourth quarter despite “robust momentum across the business.” ...

Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...